Back
ProShares Ultra MSCI Brazil Capped Vs. Avidity Biosciences Industry Stock Comparison
Buy
65
UBR
ProShares Ultra MSCI Brazil Capped
Last Price:
24.08
Seasonality Move:
-2.83%
Sell
33
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
65
ProShares Ultra MSCI Brazil Capped (UBR)
is a Buy
Is ProShares Ultra MSCI Brazil Capped a Buy, Sell or Hold?
- The current ProShares Ultra MSCI Brazil Capped [UBR] share price is $24.29. The Score for UBR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- UBR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UBR Stock Price Chart
What is ProShares Ultra MSCI Brazil Capped's stock price today?
-
The ProShares Ultra MSCI Brazil Capped share price today is $24.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UBR is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
UBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 55.69 | Buy |
Chaikin Money Flow: | -612 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.31 - 25.07) | Buy |
Bollinger Bands (100): | (21.13 - 25.53) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 62 | Buy |
Chaikin Money Flow: | 402350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.19 - 44.69) | Buy |
Bollinger Bands (100): | (30.3 - 45.36) | Buy |
UBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.64 | Buy |
20-day SMA: | 23.95 | Buy |
50-day SMA: | 23 | Buy |
200-day SMA: | 26.49 | Sell |
8-day EMA: | 23.92 | Buy |
20-day EMA: | 23.77 | Buy |
50-day EMA: | 23.43 | Buy |
200-day EMA: | 25 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.33 | Buy |
20-day SMA: | 42.39 | Buy |
50-day SMA: | 43.82 | Buy |
200-day SMA: | 26.96 | Buy |
8-day EMA: | 43.04 | Buy |
20-day EMA: | 42.7 | Buy |
50-day EMA: | 41.84 | Buy |
200-day EMA: | 30.49 | Buy |
ProShares Ultra MSCI Brazil Capped Earnings Growth & UBR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
ProShares Ultra MSCI Brazil Capped Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |